Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Recce Pharmaceuticals Ltd has announced an application for the quotation of 17,777,788 new ordinary shares on the ASX under the code RCE, with the issue date set for July 9, 2024. This move, aimed at enhancing the company’s financial landscape, is detailed in the company’s latest Appendix 2A filing with the Australian Securities Exchange.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
